Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore the question of which is better for daily expenses: cash back or points. Make informed choices to maximize your rewards potential.
27,346 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A wave of headlines around massive news PayPal stock has investors scanning the market for clues. This article breaks...
Costco stock has delivered impressive long-term results, but a disciplined approach matters. This guide breaks down t...
On Tuesday, Plug Power stock moved sharply higher as investors weighed earnings and strategic momentum. This comprehe...
A contrarian approach that looks beyond flashy tech names. Learn how to find a dirt cheap growth stock with solid fun...
Rubrik faces a pivotal Q1 print, with traders watching for signs of margin expansion and cash flow improvement after ...
An $18 million wager on a rental business with decades of dividend growth sounds ambitious. This article breaks down ...
Itron stock is making big moves this week, with investors buzzing about quarterly results and smart-city demand. This...
A major trading move shows Clearline Capital expanding its Core Scientific holding just as Bitcoin mining evolves int...
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
SoFi's Galileo platform powers card programs and payments for fintech partners. This article explains why sofi's gali...
The surge in late applied digital (apld) stock has many investors asking if the window to buy has closed. This guide ...